cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports Nicotinamide N-Methyltransferase in Cardiovascular Diseases:
Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target A systems approach to NAD+ restoration ScienceDirect Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



